Form D · Other Technology

Full Genomes Corp

Rockville, MD · CIK 0001586962

Offering snapshot reported Mar 11, 2019 · SEC filing

Reported sold
$25K
Offering amount: $25K
Investors reported
1
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Dec 9, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 11, 2019Initial$25,000No comparison1SEC filing
Aug 27, 2018Initial$187,932No comparison1SEC filing
Nov 1, 2017Amendment$100,000$0vs Nov 1, 20171SEC filing
Nov 1, 2017Initial$100,000No comparison1SEC filing
May 9, 2016Initial$19,145No comparison1SEC filing
Oct 26, 2015Initial$10,000No comparison1SEC filing
Sep 14, 2015Initial$10,000No comparison1SEC filing
Dec 9, 2014Initial$10,000No comparison1SEC filing
Sep 17, 2013Initial$250,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-334521
12,500 shares sold to Abdullah Marafi

Source: Form D, filed Mar 11, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ian Burbulis Director
Nong Chen Director, Executive
Paul Conroy Director
Leon Kull Director
Justin Allen Loe Director, Executive
Abdullah Marafi Director
Nicolas Taban Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
2275 Research Blvd., Suite 500
Rockville, MD, 20850